Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Ludwig Enterprises Inc LUDG

Healthcare Biotechnology
Ludwig Enterprises is a publicly traded Medical Technology Holding Company with Precision Genomics, Inc. and MyRNA for Life, Inc. as wholly owned subsidiaries. Advancements in medical technology and Artificial Intelligence (AI) have awarded us with cutting-edge genomic tools, unheard-of even a generation ago. These genomic tools have the potential to not only detect diseases early but also to... see more

Recent & Breaking News (OTCPK:LUDG)

Ludwig Enterprises Begins PCR Validation Test Process

Accesswire November 7, 2024

Ludwig Enterprises Files Provisional Patent for Revolutionary Cancer Screening Algorithm, Plans 2024 Launch as Revealia(TM)

Accesswire October 24, 2024

CORRECTING AND REPLACING: Ludwig Enterprises Inc. Announces AI-Powered Cancer Screening Technology

Accesswire September 24, 2024

Ludwig Enterprises Inc. Announces AI-Powered Cancer Screening Technology

Accesswire September 24, 2024

Ludwig Announces Acquisition of Intellectual Property and Patent

Accesswire September 17, 2024

Nova Mentis Assigns Intellectual Property

Newsfile August 27, 2024

Ludwig Announces Substantial Corporate Initiatives

Accesswire August 14, 2024

Ludwig Enterprises Files Provisional Patent on mRNA Genetic Screening Signals in Breast, Colon and Bladder Cancer

Accesswire July 9, 2024

Ludwig Enterprises Inc (OTC:LUDG) Funds Incurable Brain Cancer Study

Accesswire March 27, 2024

Ludwig Enterprises Inc (OTC:LUDG) Enters Booming Artificial Intelligence Cancer Screening Market with its Non-Invasive Cancer Diagnostics Testing Kit, launching within 2024

GlobeNewswire March 19, 2024

Ludwig Enterprises Inc. (OTC:LUDG) Announces Patent Filing for Breakthrough in Identifying mRNA Genes Associated with Certain Cancers

GlobeNewswire March 6, 2024

Ludwig Enterprises mRNA Bladder Cancer Study to be Launched

Accesswire January 31, 2024

Exousia AI Ludwig Enterprises Subsidiary Launches Liposome Research Program

Accesswire January 9, 2024

Ludwig Enterprises Appoints Scott Silverman as CFO

Accesswire November 16, 2023

Ludwig Enterprises Announces Effectiveness of Form S-1 Registration Application, Becomes an SEC Reporting Company

Accesswire November 14, 2023

Ludwig Enterprises, Inc. Announces Marvin S. Hausman, M.D. as Chief Executive Officer

Accesswire September 19, 2023

LUDG Files Genomic Patent AI Uncovers Differentially Expressed Genes

Accesswire May 9, 2023

Ludwig Enterprises to Launch New Nutraceutical in Hair Loss Market

Accesswire May 3, 2023

Ludwig Enterprises Announces Launch of New Nutraceutical and Strategic Marketing Plan

Accesswire April 25, 2023

Ludwig Enterprises Launches NuGenea, Groundbreaking Nutraceutical to Fight Inflammation

Accesswire April 12, 2023